Skip to content

Internet usage questionnaire survey on behavioral change after viewing the website "gen-shu.jp" of drinkers enhancing the risk of lifestyle-related diseases

Internet usage questionnaire survey on behavioral change after viewing the website "gen-shu.jp" of drinkers enhancing the risk of lifestyle-related diseases - Internet usage questionnaire survey on behavioral change after viewing the website "gen-shu.jp"

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000043043
Enrollment
600
Registered
2021-01-18
Start date
2021-02-22
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

alcohol consumption

Interventions

Website &quot
gen-shu.jp&quot
unviewed panels view the three items on the website &quot

Sponsors

Otsuka Pharmaceutical Co., Ltd
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Drinkers enhancing the risk of lifestyle-related diseases (drinkers of 40g/day or more male and 20g/day or more female: risk drinkers) Risk drinkers who have weekly or more drinking alcohol control problem (risk drinkers who have drinking alcohol control problem) risk drinkers who have been advised to refrain from alcohol by others during the last year (risk drinkers who have been worried about drinking by others).

Exclusion criteria

Exclusion criteria: Subjects who have viewed the website "gen-shu.jp" before the study.

Design outcomes

Primary

MeasureTime frame
Behavior change hope incidence rate of immediately after the viewing of the website

Secondary

MeasureTime frame
Rate of change without intention to reduce alcohol, rate of change without intention to consult, rate of change without intention to treat, rate of transition to correct answer of risk drinking levels for men and women, and rate of risk-free drinkers 1 month after viewing website

Countries

Japan

Contacts

Public ContactYoshihiro Tadori

Otsuka Pharmaceutical Co., Ltd Medical Affairs

Tadori.Yoshihiro@otsuka.jp080-8720-3458

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026